Skip to main content
  • English
    • Nederlands
    • Français

Home
  • Sign In
  • Therapeutic areas
    • Cardiology
      • Heart Failure
      • ASCVD
    • Dermatology
    • Hematology
      • ITP
    • Neurology
      • Multiple Sclerosis
    • Oncology
      • Breast Cancer
      • Prostate Cancer (mCRPC)
    • Ophthalmology
      • Retinal diseases
    • Respiratory
    • Rheumatology
  • Congresses & Events
    • Cardiology
      • BSC
      • ESC
    • Dermatology
      • EADV
      • Sharing is Caring
    • Hematology
      • ASH
      • EHA
      • ESH
    • Neurology
      • CMSC
      • EAN
      • ECTRIMS
    • Oncology
      • ASCO
      • ESMO
      • EBCC
      • SABCS
    • Rheumatology
      • Sharing is Caring
  • Contact

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

IMPACT event: Innovation and Multidisciplinary care with Pluvicto for Advanced mCRPC patients
Page protected by password
Netelroos - Doe the test
Search
  • 220 study

    Read more about the 220 study, such as the study design and the most important results.

    Study design 1

    The patient population consisted of 162 patients with BRAF and/or Mek treatment-naïve melanoma in a...

    Twitter Linkedin Facebook Pinterest Google plus
  • COMBI-v study

    Read more about the COMBI-v study, such as the study design and the most important results.

    Study design 1

    The patient population consisted of 704 patients with unresectable (Stage IIIC) or metastatic (...

    Twitter Linkedin Facebook Pinterest Google plus
  • Pooled analysis from COMBI-v and COMBI-d

    Read more about the COMBI-v and COMBI-d study, such as the study design and the most important results.

    Pooled analysis 1

    An analysis has been done on pooled extended-survival data from two phase III...

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety profile

    Twitter Linkedin Facebook Pinterest Google plus
  • Mechanism of Action

    Twitter Linkedin Facebook Pinterest Google plus
  • ESH Berlin 2023 Highlights

    Twitter Linkedin Facebook Pinterest Google plus
  • Indications

    Twitter Linkedin Facebook Pinterest Google plus
  • Reimbursement

    Twitter Linkedin Facebook Pinterest Google plus
  • Cosentyx® Reimbursement form Initiation A (French)

      Download French document    
  • Cosentyx® Reimbursement form Initiation A (Dutch)

      Download Dutch document    
  • previous
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
 of  17
  • next

Filter by specialism:

Subscribe to Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sitemap
Cookie Settings
©2025 Novartis Belgium and Luxembourg
  • Terms of use
  • Privacy Policy
  • About cookies
This website is intended for health care professionals in Belgium and Luxembourg